- Home
- EZPW vs IMTX Comparison
EZPW vs IMTX Comparison
Compare EZPW & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EZPW
- IMTX
- Stock Information
- Founded
- EZPW 1989
- IMTX N/A
- Country
- EZPW United States
- IMTX Germany
- Employees
- EZPW N/A
- IMTX N/A
- Industry
- EZPW Other Specialty Stores
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EZPW Consumer Discretionary
- IMTX Health Care
- Exchange
- EZPW Nasdaq
- IMTX Nasdaq
- Market Cap
- EZPW 814.0M
- IMTX 653.9M
- IPO Year
- EZPW 1991
- IMTX N/A
- Fundamental
- Price
- EZPW $14.25
- IMTX $6.00
- Analyst Decision
- EZPW Strong Buy
- IMTX Strong Buy
- Analyst Count
- EZPW 3
- IMTX 4
- Target Price
- EZPW $19.33
- IMTX $14.67
- AVG Volume (30 Days)
- EZPW 821.6K
- IMTX 662.2K
- Earning Date
- EZPW 07-30-2025
- IMTX 08-12-2025
- Dividend Yield
- EZPW N/A
- IMTX N/A
- EPS Growth
- EZPW 18.94
- IMTX N/A
- EPS
- EZPW 1.19
- IMTX N/A
- Revenue
- EZPW $1,202,458,000.00
- IMTX $155,801,989.00
- Revenue This Year
- EZPW $9.25
- IMTX N/A
- Revenue Next Year
- EZPW $6.38
- IMTX $1.92
- P/E Ratio
- EZPW $12.01
- IMTX N/A
- Revenue Growth
- EZPW 8.14
- IMTX 93.56
- 52 Week Low
- EZPW $9.80
- IMTX $3.30
- 52 Week High
- EZPW $16.60
- IMTX $13.09
- Technical
- Relative Strength Index (RSI)
- EZPW 60.14
- IMTX 61.02
- Support Level
- EZPW $13.34
- IMTX $5.50
- Resistance Level
- EZPW $14.25
- IMTX $6.17
- Average True Range (ATR)
- EZPW 0.38
- IMTX 0.28
- MACD
- EZPW 0.08
- IMTX 0.02
- Stochastic Oscillator
- EZPW 98.91
- IMTX 81.38
About EZPW EZCORP Inc. Non Voting
EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buy and sell second-hand goods. The operating segments of the company are us Pawn, Latin America Pawn, and other international. us Pawn segment includes all pawn activities in the United States. Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales which are primarily collateral forfeited from pawn lending operations and used merchandise purchased from the customers.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.